Convatec Group Plc (CNVVY)
11.47
-0.07
(-0.61%)
USD |
OTCM |
Oct 02, 16:00
Convatec Group Cash from Operations (TTM) : 383.49M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 383.49M |
| December 31, 2025 | 468.24M |
| June 30, 2025 | 480.24M |
| December 31, 2024 | 396.20M |
| June 30, 2024 | 350.34M |
| December 31, 2023 | 356.74M |
| June 30, 2023 | 248.59M |
| December 31, 2022 | 295.49M |
| June 30, 2022 | 301.45M |
| December 31, 2021 | 308.75M |
| June 30, 2021 | 369.74M |
| Date | Value |
|---|---|
| December 31, 2020 | 392.34M |
| June 30, 2020 | 369.10M |
| December 31, 2019 | 407.20M |
| June 30, 2019 | 391.61M |
| December 31, 2018 | 362.51M |
| June 30, 2018 | 343.73M |
| December 31, 2017 | 299.73M |
| June 30, 2017 | 147.08M |
| December 31, 2016 | 79.18M |
| June 30, 2016 | 127.39M |
| December 31, 2015 | 99.99M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Smith & Nephew plc | 1.330B |
| Tristel Plc | 14.21M |
| Abingdon Health Plc | -2.974M |
| Creo Medical Group Plc | -57.78M |
| Abbott Laboratories | 9.905B |